Maintenance Treatment With Bevacizumab and Atezolizumab for Ovarian Cancer

Clinical trial NCT04510584 · WITHDRAWN

Trial details

NCT number: NCT04510584
Sponsor: University Health Network, Toronto
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Endometrioid Tumor Fallopian Tube Cancer Primary Peritoneal Cancer TP53 Mutation

Start date: 2021-07-16
Primary completion: 2023-02-22
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.